Multiscale deep learning framework captures systemic immune features in lymph nodes predictive of triple negative breast cancer outcome in large-scale studies.


Journal

The Journal of pathology
ISSN: 1096-9896
Titre abrégé: J Pathol
Pays: England
ID NLM: 0204634

Informations de publication

Date de publication:
08 2023
Historique:
revised: 27 02 2023
received: 09 09 2022
accepted: 11 04 2023
medline: 13 7 2023
pubmed: 26 5 2023
entrez: 25 5 2023
Statut: ppublish

Résumé

The suggestion that the systemic immune response in lymph nodes (LNs) conveys prognostic value for triple-negative breast cancer (TNBC) patients has not previously been investigated in large cohorts. We used a deep learning (DL) framework to quantify morphological features in haematoxylin and eosin-stained LNs on digitised whole slide images. From 345 breast cancer patients, 5,228 axillary LNs, cancer-free and involved, were assessed. Generalisable multiscale DL frameworks were developed to capture and quantify germinal centres (GCs) and sinuses. Cox regression proportional hazard models tested the association between smuLymphNet-captured GC and sinus quantifications and distant metastasis-free survival (DMFS). smuLymphNet achieved a Dice coefficient of 0.86 and 0.74 for capturing GCs and sinuses, respectively, and was comparable to an interpathologist Dice coefficient of 0.66 (GC) and 0.60 (sinus). smuLymphNet-captured sinuses were increased in LNs harbouring GCs (p < 0.001). smuLymphNet-captured GCs retained clinical relevance in LN-positive TNBC patients whose cancer-free LNs had on average ≥2 GCs, had longer DMFS (hazard ratio [HR] = 0.28, p = 0.02) and extended GCs' prognostic value to LN-negative TNBC patients (HR = 0.14, p = 0.002). Enlarged smuLymphNet-captured sinuses in involved LNs were associated with superior DMFS in LN-positive TNBC patients in a cohort from Guy's Hospital (multivariate HR = 0.39, p = 0.039) and with distant recurrence-free survival in 95 LN-positive TNBC patients of the Dutch-N4plus trial (HR = 0.44, p = 0.024). Heuristic scoring of subcapsular sinuses in LNs of LN-positive Tianjin TNBC patients (n = 85) cross-validated the association of enlarged sinuses with shorter DMFS (involved LNs: HR = 0.33, p = 0.029 and cancer-free LNs: HR = 0.21 p = 0.01). Morphological LN features reflective of cancer-associated responses are robustly quantifiable by smuLymphNet. Our findings further strengthen the value of assessment of LN properties beyond the detection of metastatic deposits for prognostication of TNBC patients. © 2023 The Authors. The Journal of Pathology published by John Wiley & Sons Ltd on behalf of The Pathological Society of Great Britain and Ireland.

Identifiants

pubmed: 37230111
doi: 10.1002/path.6088
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

376-389

Subventions

Organisme : Cancer Research UK
ID : CRUK/07/012
Pays : United Kingdom
Organisme : Cancer Research UK
ID : KCL-BCN-Q3
Pays : United Kingdom
Organisme : Medical Research Council
ID : MR/X012476/1
Pays : United Kingdom
Organisme : Cancer Research UK
ID : CTRQQR-2021/100004
Pays : United Kingdom

Informations de copyright

© 2023 The Authors. The Journal of Pathology published by John Wiley & Sons Ltd on behalf of The Pathological Society of Great Britain and Ireland.

Références

du Bois H, Heim TA, Lund AW. Tumor-draining lymph nodes: at the crossroads of metastasis and immunity. Sci Immunol 2021; 6: eabg3551.
Giuliano AE, Ballman KV, McCall L, et al. Effect of axillary dissection vs no axillary dissection on 10-year overall survival among women with invasive breast cancer and sentinel node metastasis: the ACOSOG Z0011 (alliance) randomized clinical trial. JAMA 2017; 318: 918-926.
Galimberti V, Cole BF, Viale G, et al. Axillary dissection versus no axillary dissection in patients with breast cancer and sentinel-node micrometastases (IBCSG 23-01): 10-year follow-up of a randomised, controlled phase 3 trial. Lancet Oncol 2018; 19: 1385-1393.
Sato J, Doi T, Kanno T, et al. Histopathology of incidental findings in cynomolgus monkeys (Macaca fascicularis) used in toxicity studies. J Toxicol Pathol 2012; 25: 63-101.
Litjens G, Bandi P, Ehteshami Bejnordi B, et al. 1399 H&E-stained sentinel lymph node sections of breast cancer patients: the CAMELYON dataset. Gigascience 2018; 7: giy065.
van der Laak J, Litjens G, Ciompi F. Deep learning in histopathology: the path to the clinic. Nat Med 2021; 27: 775-784.
Liu F, Hardiman T, Wu K, et al. Systemic immune reaction in axillary lymph nodes adds to tumor-infiltrating lymphocytes in triple-negative breast cancer prognostication. NPJ Breast Cancer 2021; 7: 86.
Grigoriadis A, Gazinska P, Pai T, et al. Histological scoring of immune and stromal features in breast and axillary lymph nodes is prognostic for distant metastasis in lymph node-positive breast cancers. J Pathol Clin Res 2018; 4: 39-54.
Quintana A, Peg V, Prat A, et al. Immune analysis of lymph nodes in relation to the presence or absence of tumor infiltrating lymphocytes in triple-negative breast cancer. Eur J Cancer 2021; 148: 134-145.
Seidl M, Bader M, Vaihinger A, et al. Morphology of immunomodulation in breast cancer tumor draining lymph nodes depends on stage and intrinsic subtype. Sci Rep 2018; 8: 5321.
Pham HHN, Futakuchi M, Bychkov A, et al. Detection of lung cancer lymph node metastases from whole-slide histopathologic images using a two-step deep learning approach. Am J Pathol 2019; 189: 2428-2439.
Bera K, Schalper KA, Rimm DL, et al. Artificial intelligence in digital pathology - new tools for diagnosis and precision oncology. Nat Rev Clin Oncol 2019; 16: 703-715.
Ronneberger O, Fischer P, Brox T. U-net: convolutional networks for biomedical image segmentation. In Medical Image Computing and Computer-Assisted Intervention - MICCAI 2015, Navab N, Hornegger J, Wells W, et al. (eds). Springer International Publishing: Cham, 2015; 234-241.
Shelhamer E, Long J, Darrell T. Fully convolutional networks for semantic segmentation. IEEE Trans Pattern Anal Mach Intell 2017; 39: 640-651.
Su R, Zhang D, Liu J, et al. MSU-net: multi-scale U-net for 2D medical image segmentation. Front Genet 2021; 12: 639930.
Vollebergh MA, Lips EH, Nederlof PM, et al. Genomic patterns resembling BRCA1- and BRCA2-mutated breast cancers predict benefit of intensified carboplatin-based chemotherapy. Breast Cancer Res 2014; 16: R47.
Alberts E, Wall I, Calado DP, et al. Immune crosstalk between lymph nodes and breast carcinomas, with a focus on B cells. Front Mol Biosci 2021; 8: 673051.
McShane LM, Altman DG, Sauerbrei W, et al. REporting recommendations for tumour MARKer prognostic studies (REMARK). Br J Cancer 2005; 93: 387-391.
Otsu N. A threshold selection method from gray level histograms. IEEE Trans Syst Man Cybern 1979; 9: 62-66.
Li Y, Ping W. Cancer metastasis detection with neural conditional random field. ArXiv 2018; abs/1806.07064. [see also https://openreview.net/forum?id=S1aY66iiM].
Oktay O, Schlemper J, Folgoc LL, et al. Attention U-net: learning where to look for the pancreas. ArXiv 2018; abs/1804.03999. [see also https://openreview.net/forum?id=Skft7cijM].
Kurian NC, Lohan A, Verghese G, et al. Deep multi-scale U-Net architecture and label-noise robust training strategies for histopathological image segmentation. In 2022 IEEE 22nd International Conference on Bioinformatics and Bioengineering (BIBE). IEEE: Taichung, 2022; 91-96.
Bankhead P, Loughrey MB, Fernández JA, et al. QuPath: open source software for digital pathology image analysis. Sci Rep 2017; 7: 16878.
Sørensen TJ. A Method of Establishing Groups of Equal Amplitude in Plant Sociology based on Similarity of Species Content and its Application to Analyses of the Vegetation on Danish Commons. I kommission hos E. Munksgaard: København, 1948.
Gourgou-Bourgade S, Cameron D, Poortmans P, et al. Guidelines for time-to-event end point definitions in breast cancer trials: results of the DATECAN initiative (definition for the assessment of time-to-event endpoints in CANcer trials)†. Ann Oncol 2015; 26: 873-879.
Team RC. R: A Language and Environment for Statistical Computing. R Foundation for Statistical Computing: Vienna, 2013.
Kleppe A, Skrede O-J, De Raedt S, et al. Designing deep learning studies in cancer diagnostics. Nat Rev Cancer 2021; 21: 199-211.
Steenbruggen TG, Steggink LC, Seynaeve CM, et al. High-dose chemotherapy with hematopoietic stem cell transplant in patients with high-risk breast cancer and 4 or more involved axillary lymph nodes: 20-year follow-up of a phase 3 randomized clinical trial. JAMA Oncol 2020; 6: 528-534.
Habenicht LM, Kirschbaum SB, Furuya M, et al. Tumor regulation of lymph node lymphatic sinus growth and lymph flow in mice and in humans. Yale J Biol Med 2017; 90: 403-415.
Batista FD, Harwood NE. The who, how and where of antigen presentation to B cells. Nat Rev Immunol 2009; 9: 15-27.
Kastenmüller W, Torabi-Parizi P, Subramanian N, et al. A spatially-organized multicellular innate immune response in lymph nodes limits systemic pathogen spread. Cell 2012; 150: 1235-1248.
Komohara Y, Ohnishi K, Takeya M. Possible functions of CD169-positive sinus macrophages in lymph nodes in anti-tumor immune responses. Cancer Sci 2017; 108: 290-295.
Pucci F, Garris C, Lai CP, et al. SCS macrophages suppress melanoma by restricting tumor-derived vesicle-B cell interactions. Science 2016; 352: 242-246.
Marini N, Otálora S, Podareanu D, et al. Multi_Scale_Tools: a python library to exploit multi-scale whole slide images. Front Comput Sci 2021; 3: 684521.
López-Pérez M, Amgad M, Morales-Álvarez P, et al. Learning from crowds in digital pathology using scalable variational gaussian processes. Sci Rep 2021; 11: 11612.
Schmid P, Cortes J, Pusztai L, et al. Pembrolizumab for early triple-negative breast cancer. N Engl J Med 2020; 382: 810-821.
Sun P, He J, Chao X, et al. A computational tumor-infiltrating lymphocyte assessment method comparable with visual reporting guidelines for triple-negative breast cancer. EBioMedicine 2021; 70: 103492.
Acs B, Salgado R, Hartman J. What do we still need to learn on digitally assessed biomarkers? EBioMedicine 2021; 70: 103520.
Warnat-Herresthal S, Schultze H, Shastry KL, et al. Swarm learning for decentralized and confidential clinical machine learning. Nature 2021; 594: 265-270.
Shmatko A, Ghaffari Laleh N, Gerstung M, et al. Artificial intelligence in histopathology: enhancing cancer research and clinical oncology. Nat Cancer 2022; 3: 1026-1038.

Auteurs

Gregory Verghese (G)

Cancer Bioinformatics, School of Cancer & Pharmaceutical Sciences, Faculty of Life Sciences and Medicine, King's College London, London, UK.
School of Cancer & Pharmaceutical Sciences, Faculty of Life Sciences and Medicine, King's College London, London, UK.
Breast Cancer Now Unit, School of Cancer and Pharmaceutical Sciences, Faculty of Life Sciences and Medicine, King's College London, London, UK.

Mengyuan Li (M)

Cancer Bioinformatics, School of Cancer & Pharmaceutical Sciences, Faculty of Life Sciences and Medicine, King's College London, London, UK.
School of Cancer & Pharmaceutical Sciences, Faculty of Life Sciences and Medicine, King's College London, London, UK.

Fangfang Liu (F)

Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Tianjin's Clinical Research Center for Cancer, Key Laboratory of Breast Cancer Prevention and Therapy, Tianjin Medical University, Ministry of Education, Key Laboratory of Cancer Prevention and Therapy, Tianjin, PR China.

Amit Lohan (A)

Department of Electrical Engineering, Indian Institute of Technology Bombay, Mumbai, India.

Nikhil Cherian Kurian (NC)

Department of Electrical Engineering, Indian Institute of Technology Bombay, Mumbai, India.

Swati Meena (S)

Department of Electrical Engineering, Indian Institute of Technology Bombay, Mumbai, India.

Patrycja Gazinska (P)

Breast Cancer Now Unit, School of Cancer and Pharmaceutical Sciences, Faculty of Life Sciences and Medicine, King's College London, London, UK.
Biobank Research Group, Lukasiewicz Research Network, PORT Polish Center for Technology Development, Wroclaw, Poland.

Aekta Shah (A)

Cancer Bioinformatics, School of Cancer & Pharmaceutical Sciences, Faculty of Life Sciences and Medicine, King's College London, London, UK.
Department of Pathology, Tata Memorial Centre, Tata Memorial Hospital, Homi Bhabha National Institute, Mumbai, India.

Aasiyah Oozeer (A)

King's Health Partners Cancer Biobank, King's College London, London, UK.

Terry Chan (T)

Division of Molecular Pathology, The Netherlands Cancer Institute, Amsterdam, The Netherlands.

Mark Opdam (M)

Division of Molecular Pathology, The Netherlands Cancer Institute, Amsterdam, The Netherlands.

Sabine Linn (S)

Division of Molecular Pathology, The Netherlands Cancer Institute, Amsterdam, The Netherlands.
Department of Medical Oncology, The Netherlands Cancer Institute, Antoni van Leeuwenhoek, Amsterdam, The Netherlands.
Department of Pathology, University Medical Centre, Utrecht, The Netherlands.

Cheryl Gillett (C)

King's Health Partners Cancer Biobank, King's College London, London, UK.

Elena Alberts (E)

Cancer Bioinformatics, School of Cancer & Pharmaceutical Sciences, Faculty of Life Sciences and Medicine, King's College London, London, UK.
School of Cancer & Pharmaceutical Sciences, Faculty of Life Sciences and Medicine, King's College London, London, UK.

Thomas Hardiman (T)

Cancer Bioinformatics, School of Cancer & Pharmaceutical Sciences, Faculty of Life Sciences and Medicine, King's College London, London, UK.
School of Cancer & Pharmaceutical Sciences, Faculty of Life Sciences and Medicine, King's College London, London, UK.

Samantha Jones (S)

Centre for Tumour Biology, Barts Cancer Institute, Queen Mary University of London, London, UK.

Selvam Thavaraj (S)

Faculty of Dentistry, Oral & Craniofacial Science, King's College London, London, UK.
Head and Neck Pathology, Guy's & St Thomas' NHS Foundation Trust, London, UK.

J Louise Jones (JL)

Centre for Tumour Biology, Barts Cancer Institute, Queen Mary University of London, London, UK.

Roberto Salgado (R)

Department of Pathology, GZA-ZNA Hospitals, Antwerp, Belgium.
Division of Research, Peter Mac Callum Cancer Centre, Melbourne, Australia.

Sarah E Pinder (SE)

School of Cancer & Pharmaceutical Sciences, Faculty of Life Sciences and Medicine, King's College London, London, UK.

Swapnil Rane (S)

Department of Pathology, Tata Memorial Centre-ACTREC, HBNI, Mumbai, India.

Amit Sethi (A)

Department of Electrical Engineering, Indian Institute of Technology Bombay, Mumbai, India.

Anita Grigoriadis (A)

Cancer Bioinformatics, School of Cancer & Pharmaceutical Sciences, Faculty of Life Sciences and Medicine, King's College London, London, UK.
School of Cancer & Pharmaceutical Sciences, Faculty of Life Sciences and Medicine, King's College London, London, UK.
Breast Cancer Now Unit, School of Cancer and Pharmaceutical Sciences, Faculty of Life Sciences and Medicine, King's College London, London, UK.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH